Your new post is loading...
By Anna Azvolinsky, LiveScience Contributor Published: 12/04/2013 03:25 PM EST on LiveScience A sensitive new DNA test can predict how long ovarian cancer patients will survive, and guide personalized treatment decisions, according to new research.
|
Scooped by Alfredo Corell |
Scoop.it!
No comment yet.
Sign up to comment
The technology, called QuanTILfy, counts the number of cells called tumor-infiltrating lymphocytes (TILs) in a cancer patient's tumor biopsy. Cancer patientswith more of these cells in their tumor tend to have better outcomes, previous studies in ovarian, colorectal and other cancers have shown.
A divulgative new in spanish: http://www.elmundo.es/salud/2013/12/09/52a0d4010ab740f5568b458f.html ;
The original publication
Sci Transl Med 4 December 2013:
Vol. 5, Issue 214, p. 214ra169
Sci. Transl. Med. DOI: 10.1126/scitranslmed.3007247
http://stm.sciencemag.org/content/5/214/214ra169.short ;